Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00162110
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2005-09-09
Brief Title:
A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces
Sponsor:
Organization:
Eli Lilly and Company